Thermo Fisher Scientific Analyst Ratings
Thermo Fisher Scientific Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/26/2023 | 20.18% | Citigroup | $625 → $530 | Maintains | Buy |
10/26/2023 | 16.78% | Raymond James | $580 → $515 | Maintains | Outperform |
10/26/2023 | 23.58% | Morgan Stanley | $600 → $545 | Maintains | Overweight |
10/26/2023 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
10/24/2023 | 36.05% | Morgan Stanley | $640 → $600 | Maintains | Overweight |
10/18/2023 | 31.52% | Raymond James | $630 → $580 | Maintains | Outperform |
10/17/2023 | 42.86% | JP Morgan | $670 → $630 | Maintains | Overweight |
10/02/2023 | 41.72% | Citigroup | $625 → $625 | Reiterates | Buy → Buy |
09/28/2023 | 36.73% | Bernstein | → $603 | Initiates Coverage On | → Outperform |
09/06/2023 | 41.72% | Citigroup | → $625 | Reinstates | Buy → Buy |
07/28/2023 | 17.91% | Wells Fargo | $505 → $520 | Maintains | Underweight |
07/28/2023 | 42.86% | Raymond James | $595 → $630 | Maintains | Outperform |
07/27/2023 | 45.12% | Morgan Stanley | $620 → $640 | Maintains | Overweight |
07/27/2023 | 58.28% | RBC Capital | $662 → $698 | Maintains | Outperform |
07/27/2023 | 51.93% | JP Morgan | $660 → $670 | Maintains | Overweight |
07/27/2023 | 41.72% | Baird | $664 → $625 | Maintains | Outperform |
07/27/2023 | 41.72% | Barclays | $590 → $625 | Maintains | Overweight |
07/13/2023 | 40.59% | Credit Suisse | → $620 | Upgrades | Neutral → Outperform |
05/25/2023 | 49.66% | JP Morgan | $675 → $660 | Maintains | Overweight |
05/25/2023 | 45.12% | Keybanc | $710 → $640 | Maintains | Overweight |
04/27/2023 | 47.39% | Citigroup | $700 → $650 | Maintains | Buy |
04/27/2023 | 50.11% | RBC Capital | $664 → $662 | Maintains | Outperform |
04/27/2023 | 40.59% | Morgan Stanley | $670 → $620 | Maintains | Overweight |
04/27/2023 | 57.14% | TD Cowen | $711 → $693 | Maintains | Outperform |
04/27/2023 | 51.93% | Baird | $693 → $670 | Maintains | Outperform |
04/27/2023 | 38.32% | Barclays | $625 → $610 | Maintains | Overweight |
04/04/2023 | 38.32% | Evercore ISI Group | $615 → $610 | Maintains | Outperform |
04/04/2023 | 41.72% | Barclays | $660 → $625 | Maintains | Overweight |
02/02/2023 | 53.06% | JP Morgan | $650 → $675 | Maintains | Overweight |
02/02/2023 | 61.22% | Cowen & Co. | $690 → $711 | Maintains | Outperform |
02/02/2023 | 58.73% | Citigroup | $650 → $700 | Maintains | Buy |
02/02/2023 | 51.93% | Morgan Stanley | $613 → $670 | Maintains | Overweight |
02/02/2023 | 49.66% | Barclays | $630 → $660 | Maintains | Overweight |
02/02/2023 | 42.86% | SVB Leerink | $620 → $630 | Maintains | Outperform |
01/24/2023 | 42.86% | Barclays | $570 → $630 | Maintains | Overweight |
01/06/2023 | 40.59% | SVB Leerink | $555 → $620 | Maintains | Outperform |
01/03/2023 | 14.51% | Wells Fargo | $525 → $505 | Maintains | Underweight |
12/14/2022 | 40.59% | Deutsche Bank | → $620 | Initiates Coverage On | → Buy |
12/07/2022 | 49.89% | RBC Capital | → $661 | Initiates Coverage On | → Outperform |
11/29/2022 | 29.25% | Barclays | $575 → $570 | Maintains | Overweight |
11/01/2022 | 50.79% | Baird | $695 → $665 | Maintains | Outperform |
10/27/2022 | 47.39% | JP Morgan | $715 → $650 | Maintains | Overweight |
10/27/2022 | 47.39% | Citigroup | $715 → $650 | Maintains | Buy |
10/27/2022 | 30.39% | Barclays | $595 → $575 | Maintains | Overweight |
10/27/2022 | 39% | Morgan Stanley | $678 → $613 | Maintains | Overweight |
10/27/2022 | 25.85% | SVB Leerink | $590 → $555 | Maintains | Outperform |
09/12/2022 | 34.92% | Barclays | $685 → $595 | Maintains | Overweight |
08/25/2022 | 53.06% | Credit Suisse | → $675 | Initiates Coverage On | → Neutral |
08/01/2022 | 55.33% | Barclays | $630 → $685 | Maintains | Overweight |
07/29/2022 | 62.13% | JP Morgan | $700 → $715 | Maintains | Overweight |
07/29/2022 | 53.74% | Morgan Stanley | $670 → $678 | Maintains | Overweight |
07/29/2022 | 47.39% | SVB Leerink | $630 → $650 | Maintains | Outperform |
07/13/2022 | 42.86% | Barclays | $675 → $630 | Maintains | Overweight |
04/29/2022 | 51.93% | Morgan Stanley | $700 → $670 | Maintains | Overweight |
04/25/2022 | 19.05% | Wells Fargo | $605 → $525 | Downgrades | Equal-Weight → Underweight |
02/03/2022 | 37.19% | Wells Fargo | $700 → $605 | Maintains | Equal-Weight |
12/14/2021 | 58.73% | Wells Fargo | $625 → $700 | Maintains | Equal-Weight |
10/28/2021 | 62.13% | Citigroup | $700 → $715 | Maintains | Buy |
10/28/2021 | 55.33% | SVB Leerink | $675 → $685 | Maintains | Outperform |
10/20/2021 | 58.73% | Citigroup | $620 → $700 | Upgrades | Neutral → Buy |
09/23/2021 | 48.53% | Cowen & Co. | $560 → $655 | Maintains | Outperform |
09/22/2021 | 58.73% | BTIG | $610 → $700 | Maintains | Buy |
09/20/2021 | 58.73% | JP Morgan | $600 → $700 | Maintains | Overweight |
09/20/2021 | 61% | Keybanc | $555 → $710 | Maintains | Overweight |
08/04/2021 | 36.05% | Argus Research | $530 → $600 | Maintains | Buy |
07/29/2021 | 36.05% | JP Morgan | $560 → $600 | Maintains | Overweight |
07/16/2021 | 31.52% | Benchmark | → $580 | Initiates Coverage On | → Buy |
07/12/2021 | 25.85% | Keybanc | $520 → $555 | Maintains | Overweight |
06/23/2021 | 24.72% | Baird | $545 → $550 | Maintains | Outperform |
06/15/2021 | 20.18% | Goldman Sachs | $590 → $530 | Maintains | Buy |
04/16/2021 | 22.45% | Evercore ISI Group | $525 → $540 | Maintains | Outperform |
03/29/2021 | 26.98% | UBS | $588 → $560 | Maintains | Buy |
03/18/2021 | 17.91% | Keybanc | → $520 | Upgrades | Sector Weight → Overweight |
03/03/2021 | 19.05% | Barclays | → $525 | Initiates Coverage On | → Overweight |
02/03/2021 | 33.79% | BTIG | $540 → $590 | Maintains | Buy |
02/02/2021 | 20.18% | Citigroup | $500 → $530 | Maintains | Buy |
02/02/2021 | 33.33% | UBS | $566 → $588 | Maintains | Buy |
02/02/2021 | 32.65% | Cowen & Co. | $525 → $585 | Maintains | Outperform |
02/02/2021 | 36.05% | Stifel | $530 → $600 | Maintains | Buy |
02/02/2021 | 30.39% | Morgan Stanley | $535 → $575 | Maintains | Overweight |
02/02/2021 | 26.98% | SVB Leerink | $525 → $560 | Maintains | Outperform |
01/12/2021 | 31.52% | Credit Suisse | $556 → $580 | Maintains | Outperform |
01/08/2021 | 26.08% | Credit Suisse | $490 → $556 | Upgrades | Neutral → Outperform |
12/16/2020 | — | Citigroup | Downgrades | Buy → Neutral | |
12/02/2020 | 11.11% | Credit Suisse | $488 → $490 | Maintains | Neutral |
11/10/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
10/22/2020 | 10.66% | Credit Suisse | $432 → $488 | Maintains | Neutral |
10/22/2020 | 21.32% | Morgan Stanley | $485 → $535 | Maintains | Overweight |
10/22/2020 | 19.05% | SVB Leerink | $470 → $525 | Maintains | Outperform |
09/30/2020 | — | Atlantic Equities | Initiates Coverage On | → Overweight | |
09/17/2020 | 8.16% | Needham | $468 → $477 | Maintains | Buy |
09/14/2020 | 9.98% | Morgan Stanley | → $485 | Initiates Coverage On | → Overweight |
09/11/2020 | 8.84% | B of A Securities | $460 → $480 | Maintains | Buy |
09/11/2020 | -2.04% | Credit Suisse | $425 → $432 | Maintains | Neutral |
09/11/2020 | 6.58% | SVB Leerink | $455 → $470 | Maintains | Outperform |
08/21/2020 | -3.63% | Credit Suisse | $405 → $425 | Maintains | Neutral |
08/20/2020 | 4.31% | JP Morgan | → $460 | Reinstates | → Overweight |
07/23/2020 | 6.12% | Needham | $415 → $468 | Maintains | Buy |
07/23/2020 | 3.17% | SVB Leerink | $365 → $455 | Maintains | Outperform |
07/15/2020 | — | Cleveland Research | Upgrades | Neutral → Buy | |
07/07/2020 | -5.9% | Needham | $383 → $415 | Maintains | Buy |
04/23/2020 | -11.56% | Citigroup | $365 → $390 | Maintains | Buy |
04/23/2020 | -13.15% | Needham | $341 → $383 | Maintains | Buy |
04/21/2020 | -22.9% | Wells Fargo | $300 → $340 | Maintains | Equal-Weight |
04/02/2020 | -28.57% | Stifel | $345 → $315 | Maintains | Buy |
03/30/2020 | -31.97% | Wells Fargo | $345 → $300 | Maintains | Equal-Weight |
03/20/2020 | -17.23% | Citigroup | $390 → $365 | Maintains | Buy |
03/04/2020 | -22.68% | Baird | $340 → $341 | Maintains | Outperform |
01/31/2020 | -15.65% | BTIG | $342 → $372 | Maintains | Buy |
01/31/2020 | -22.9% | Baird | $319 → $340 | Maintains | Outperform |
01/31/2020 | -21.77% | Wells Fargo | $350 → $345 | Maintains | Equal-Weight |
01/31/2020 | -11.56% | Citigroup | $380 → $390 | Maintains | Buy |
01/22/2020 | -22.68% | Credit Suisse | → $341 | Initiates Coverage On | → Neutral |
01/08/2020 | -20.63% | Wells Fargo | → $350 | Initiates Coverage On | → Equal-Weight |
01/07/2020 | -13.83% | Citigroup | → $380 | Initiates Coverage On | → Buy |
11/15/2019 | -21.77% | Stifel | → $345 | Initiates Coverage On | → Buy |
10/24/2019 | -27.66% | Baird | $305 → $319 | Maintains | Outperform |
07/25/2019 | -27.21% | Needham | $315 → $321 | Maintains | Buy |
07/16/2019 | -28.57% | Needham | → $315 | Downgrades | Strong Buy → Buy |
05/23/2019 | -27.44% | UBS | $305 → $320 | Maintains | Buy |
05/01/2019 | -29.71% | Argus Research | $285 → $310 | Maintains | Buy |
03/26/2019 | -34.69% | Baird | $270 → $288 | Maintains | Outperform |
03/22/2019 | -31.97% | Deutsche Bank | $275 → $300 | Maintains | Buy |
03/18/2019 | -31.97% | Barclays | $295 → $300 | Maintains | Overweight |
01/03/2019 | -36.51% | Barclays | $275 → $280 | Maintains | Overweight |
01/03/2019 | -38.55% | Needham | → $271 | Initiates Coverage On | → Strong Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
2023年10月26日 | 20.18% | 花旗集团 | $625→$530 | 维护 | 买 |
2023年10月26日 | 16.78% | 雷蒙德·詹姆斯 | $580→$515 | 维护 | 跑赢大盘 |
2023年10月26日 | 23.58% | 摩根士丹利 | $600→$545 | 维护 | 超重 |
2023年10月26日 | - | KeyBanc | 评级下调 | 增持→板块权重 | |
2023年10月24日 | 36.05% | 摩根士丹利 | $640→$600 | 维护 | 超重 |
10/18/2023 | 31.52% | 雷蒙德·詹姆斯 | $630→$580 | 维护 | 跑赢大盘 |
10/17/2023 | 42.86% | 摩根大通 | $670→$630 | 维护 | 超重 |
10/02/2023 | 41.72% | 花旗集团 | $625→$625 | 重申 | 购买→购买 |
09/28/2023 | 36.73% | 伯恩斯坦 | →$603 | 开始承保 | →跑赢大盘 |
09/06/2023 | 41.72% | 花旗集团 | →$625 | 恢复 | 购买→购买 |
07/28/2023 | 17.91% | 富国银行 | $505→$520 | 维护 | 体重不足 |
07/28/2023 | 42.86% | 雷蒙德·詹姆斯 | $595→$630 | 维护 | 跑赢大盘 |
07/27/2023 | 45.12% | 摩根士丹利 | $620→$640 | 维护 | 超重 |
07/27/2023 | 58.28% | 加拿大皇家银行资本 | $662→$698 | 维护 | 跑赢大盘 |
07/27/2023 | 51.93% | 摩根大通 | $660→$670 | 维护 | 超重 |
07/27/2023 | 41.72% | 贝尔德 | $664→$625 | 维护 | 跑赢大盘 |
07/27/2023 | 41.72% | 巴克莱 | $590→$625 | 维护 | 超重 |
07/13/2023 | 40.59% | 瑞士信贷 | →$620 | 升级 | 中性→表现优异 |
2023年05月25日 | 49.66% | 摩根大通 | $675→$660 | 维护 | 超重 |
2023年05月25日 | 45.12% | KeyBanc | $710→$640 | 维护 | 超重 |
04/27/2023 | 47.39% | 花旗集团 | $700→$650 | 维护 | 买 |
04/27/2023 | 50.11% | 加拿大皇家银行资本 | $664→$662 | 维护 | 跑赢大盘 |
04/27/2023 | 40.59% | 摩根士丹利 | $670→$620 | 维护 | 超重 |
04/27/2023 | 57.14% | TD Cowen | $711→$693 | 维护 | 跑赢大盘 |
04/27/2023 | 51.93% | 贝尔德 | $693→$670 | 维护 | 跑赢大盘 |
04/27/2023 | 38.32% | 巴克莱 | $625→$610 | 维护 | 超重 |
04/04/2023 | 38.32% | Evercore ISI集团 | $615→$610 | 维护 | 跑赢大盘 |
04/04/2023 | 41.72% | 巴克莱 | $660→$625 | 维护 | 超重 |
02/02/2023 | 53.06% | 摩根大通 | $650→$675 | 维护 | 超重 |
02/02/2023 | 61.22% | 考恩公司 | $690→$711 | 维护 | 跑赢大盘 |
02/02/2023 | 58.73% | 花旗集团 | $650→$700 | 维护 | 买 |
02/02/2023 | 51.93% | 摩根士丹利 | $613→$670 | 维护 | 超重 |
02/02/2023 | 49.66% | 巴克莱 | $630→$660 | 维护 | 超重 |
02/02/2023 | 42.86% | SVB Leerink | $620→$630 | 维护 | 跑赢大盘 |
01/24/2023 | 42.86% | 巴克莱 | $570→$630 | 维护 | 超重 |
01/06/2023 | 40.59% | SVB Leerink | $555→$620 | 维护 | 跑赢大盘 |
01/03/2023 | 14.51% | 富国银行 | $525→$505 | 维护 | 体重不足 |
2022年12月14日 | 40.59% | 德意志银行 | →$620 | 开始承保 | →购买 |
12/07/2022 | 49.89% | 加拿大皇家银行资本 | →$661 | 开始承保 | →跑赢大盘 |
2022年11月29日 | 29.25% | 巴克莱 | $575→$570 | 维护 | 超重 |
11/01/2022 | 50.79% | 贝尔德 | $695→$665 | 维护 | 跑赢大盘 |
10/27/2022 | 47.39% | 摩根大通 | $715→$650 | 维护 | 超重 |
10/27/2022 | 47.39% | 花旗集团 | $715→$650 | 维护 | 买 |
10/27/2022 | 30.39% | 巴克莱 | $595→$575 | 维护 | 超重 |
10/27/2022 | 39% | 摩根士丹利 | $678→$613 | 维护 | 超重 |
10/27/2022 | 25.85% | SVB Leerink | $590→$555 | 维护 | 跑赢大盘 |
09/12/2022 | 34.92% | 巴克莱 | $685→$595 | 维护 | 超重 |
2022年08月25日 | 53.06% | 瑞士信贷 | →$675 | 开始承保 | →中性 |
08/01/2022 | 55.33% | 巴克莱 | $630→$685 | 维护 | 超重 |
07/29/2022 | 62.13% | 摩根大通 | $700→$715 | 维护 | 超重 |
07/29/2022 | 53.74% | 摩根士丹利 | $670→$678 | 维护 | 超重 |
07/29/2022 | 47.39% | SVB Leerink | $630→$650 | 维护 | 跑赢大盘 |
07/13/2022 | 42.86% | 巴克莱 | $675→$630 | 维护 | 超重 |
04/29/2022 | 51.93% | 摩根士丹利 | $700→$670 | 维护 | 超重 |
04/25/2022 | 19.05% | 富国银行 | $605→$525 | 评级下调 | 等重→减码 |
02/03/2022 | 37.19% | 富国银行 | $700→$605 | 维护 | 等重 |
2021年12月14日 | 58.73% | 富国银行 | $625→$700 | 维护 | 等重 |
10/28/2021 | 62.13% | 花旗集团 | $700→$715 | 维护 | 买 |
10/28/2021 | 55.33% | SVB Leerink | $675→$685 | 维护 | 跑赢大盘 |
10/20/2021 | 58.73% | 花旗集团 | $620→$700 | 升级 | 中性→购买 |
09/23/2021 | 48.53% | 考恩公司 | $560→$655 | 维护 | 跑赢大盘 |
09/22/2021 | 58.73% | BTIG | $610→$700 | 维护 | 买 |
09/20/2021 | 58.73% | 摩根大通 | $600→$700 | 维护 | 超重 |
09/20/2021 | 61% | KeyBanc | $555→$710 | 维护 | 超重 |
08/04/2021 | 36.05% | Argus研究 | $530→$600 | 维护 | 买 |
07/29/2021 | 36.05% | 摩根大通 | $560→$600 | 维护 | 超重 |
07/16/2021 | 31.52% | 基准 | →$580 | 开始承保 | →购买 |
07/12/2021 | 25.85% | KeyBanc | $520→$555 | 维护 | 超重 |
2021/06/23 | 24.72% | 贝尔德 | $545→$550 | 维护 | 跑赢大盘 |
2021/06/15 | 20.18% | 高盛 | $590→$530 | 维护 | 买 |
04/16/2021 | 22.45% | Evercore ISI集团 | $525→$540 | 维护 | 跑赢大盘 |
03/29/2021 | 26.98% | 瑞银集团 | $588→$560 | 维护 | 买 |
03/18/2021 | 17.91% | KeyBanc | →$520 | 升级 | 行业权重→超配 |
03/03/2021 | 19.05% | 巴克莱 | →$525 | 开始承保 | →超重 |
02/03/2021 | 33.79% | BTIG | $540→$590 | 维护 | 买 |
02/02/2021 | 20.18% | 花旗集团 | $500→$530 | 维护 | 买 |
02/02/2021 | 33.33% | 瑞银集团 | $566→$588 | 维护 | 买 |
02/02/2021 | 32.65% | 考恩公司 | $525→$585 | 维护 | 跑赢大盘 |
02/02/2021 | 36.05% | Stifel | $530→$600 | 维护 | 买 |
02/02/2021 | 30.39% | 摩根士丹利 | $535→$575 | 维护 | 超重 |
02/02/2021 | 26.98% | SVB Leerink | $525→$560 | 维护 | 跑赢大盘 |
2021/12/01 | 31.52% | 瑞士信贷 | $556→$580 | 维护 | 跑赢大盘 |
01/08/2021 | 26.08% | 瑞士信贷 | $490→$556 | 升级 | 中性→表现优异 |
12/16/2020 | - | 花旗集团 | 评级下调 | 购买→中性 | |
12/02/2020 | 11.11% | 瑞士信贷 | $488→$490 | 维护 | 中性 |
11/10/2020 | - | KeyBanc | 开始承保 | →行业权重 | |
10/22/2020 | 10.66% | 瑞士信贷 | $432→$488 | 维护 | 中性 |
10/22/2020 | 21.32% | 摩根士丹利 | $485→$535 | 维护 | 超重 |
10/22/2020 | 19.05% | SVB Leerink | $470→$525 | 维护 | 跑赢大盘 |
09/30/2020 | - | 大西洋证券公司 | 开始承保 | →超重 | |
09/17/2020 | 8.16% | 李约瑟 | $468→$477 | 维护 | 买 |
09/14/2020 | 9.98% | 摩根士丹利 | →$485 | 开始承保 | →超重 |
09/11/2020 | 8.84% | B of A证券 | $460→$480 | 维护 | 买 |
09/11/2020 | -2.04% | 瑞士信贷 | $425→$432 | 维护 | 中性 |
09/11/2020 | 6.58% | SVB Leerink | $455→$470 | 维护 | 跑赢大盘 |
2020年08月21日 | -3.63% | 瑞士信贷 | $405→$425 | 维护 | 中性 |
08/20/2020 | 4.31% | 摩根大通 | →$460 | 恢复 | →超重 |
07/23/2020 | 6.12% | 李约瑟 | $415→$468 | 维护 | 买 |
07/23/2020 | 3.17% | SVB Leerink | $365→$455 | 维护 | 跑赢大盘 |
07/15/2020 | - | 克利夫兰研究公司 | 升级 | 中性→购买 | |
07/07/2020 | -5.9% | 李约瑟 | $383→$415 | 维护 | 买 |
04/23/2020 | -11.56% | 花旗集团 | $365→$390 | 维护 | 买 |
04/23/2020 | -13.15% | 李约瑟 | $341→$383 | 维护 | 买 |
04/21/2020 | -22.9% | 富国银行 | $300→$340 | 维护 | 等重 |
04/02/2020 | -28.57% | Stifel | $345→$315 | 维护 | 买 |
03/30/2020 | -31.97% | 富国银行 | $345→$300 | 维护 | 等重 |
03/20/2020 | -17.23% | 花旗集团 | $390→$365 | 维护 | 买 |
03/04/2020 | -22.68% | 贝尔德 | $340→$341 | 维护 | 跑赢大盘 |
2020/01/31 | -15.65% | BTIG | $342→$372 | 维护 | 买 |
2020/01/31 | -22.9% | 贝尔德 | $319→$340 | 维护 | 跑赢大盘 |
2020/01/31 | -21.77% | 富国银行 | $350→$345 | 维护 | 等重 |
2020/01/31 | -11.56% | 花旗集团 | $380→$390 | 维护 | 买 |
2020/01/22 | -22.68% | 瑞士信贷 | →$341 | 开始承保 | →中性 |
1/08/2020 | -20.63% | 富国银行 | →$350 | 开始承保 | →等重 |
1/07/2020 | -13.83% | 花旗集团 | →$380 | 开始承保 | →购买 |
2019年11月15日 | -21.77% | Stifel | →$345 | 开始承保 | →购买 |
2019年10月24日 | -27.66% | 贝尔德 | $305→$319 | 维护 | 跑赢大盘 |
2019年07月25日 | -27.21% | 李约瑟 | $315→$321 | 维护 | 买 |
2019年07月16日 | -28.57% | 李约瑟 | →$315 | 评级下调 | 强买通→买 |
2019年05月23日 | -27.44% | 瑞银集团 | $305→$320 | 维护 | 买 |
2019年05月01日 | -29.71% | Argus研究 | $285→$310 | 维护 | 买 |
2019年03月26日 | -34.69% | 贝尔德 | $270→$288 | 维护 | 跑赢大盘 |
2019/03/22 | -31.97% | 德意志银行 | $275→$300 | 维护 | 买 |
2019/03/18 | -31.97% | 巴克莱 | $295→$300 | 维护 | 超重 |
2019年03月01日 | -36.51% | 巴克莱 | $275→$280 | 维护 | 超重 |
2019年03月01日 | -38.55% | 李约瑟 | →$271 | 开始承保 | →强势购买 |
What is the target price for Thermo Fisher Scientific (TMO)?
Thermo Fisher Science(TMO)的目标价是多少?
The latest price target for Thermo Fisher Scientific (NYSE: TMO) was reported by Citigroup on October 26, 2023. The analyst firm set a price target for $530.00 expecting TMO to rise to within 12 months (a possible 20.18% upside). 46 analyst firms have reported ratings in the last year.
花旗集团于2023年10月26日报道了Thermo Fisher Science(纽约证券交易所代码:TMO)的最新目标价。这家分析公司将目标价定为530.00美元,预计TMO将在12个月内上涨至20.18%。去年,46家分析公司公布了评级。
What is the most recent analyst rating for Thermo Fisher Scientific (TMO)?
Thermo Fisher Science(TMO)的最新分析师评级是多少?
The latest analyst rating for Thermo Fisher Scientific (NYSE: TMO) was provided by Citigroup, and Thermo Fisher Scientific maintained their buy rating.
对Thermo Fisher Science(纽约证券交易所代码:TMO)的最新分析师评级由花旗集团提供,Thermo Fisher Science维持其买入评级。
When is the next analyst rating going to be posted or updated for Thermo Fisher Scientific (TMO)?
Thermo Fisher Science(TMO)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Thermo Fisher Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Thermo Fisher Scientific was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
分析师在进行广泛的研究后得出股票评级,研究内容包括查阅公开财务报表、与赛默飞世尔科技公司的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月做一次,所以你每年应该对每家公司进行4次评级。Thermo Fisher Scientific的最后一次评级于2023年10月26日提交,因此您应该期待下一次评级将在2024年10月26日左右提供。
Is the Analyst Rating Thermo Fisher Scientific (TMO) correct?
分析师对Thermo Fisher Science(TMO)的评级正确吗?
While ratings are subjective and will change, the latest Thermo Fisher Scientific (TMO) rating was a maintained with a price target of $625.00 to $530.00. The current price Thermo Fisher Scientific (TMO) is trading at is $441.00, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的Thermo Fisher Science(TMO)评级维持不变,目标价在625.00美元至530.00美元之间。目前Thermo Fisher Science的交易价格为441.00美元,超出了分析师的预测范围。